Drug intelligence / Profile preview

DeltaFLU

Development stage
Phase 2
Lead developer
Vivaldi Biosciences
Modality
Vaccines & Immunotherapeutics
Administration
Intranasal
01

Overview

DeltaFLU is a universal influenza vaccine developed by Vivaldi Biosciences. It is administered as a nasal spray and is composed of genetically attenuated influenza vaccine strains with the NS1 gene deleted. This deletion allows DeltaFLU to induce interferon, creating a self-adjuvant effect that activates multiple immune mechanisms, including broadly cross-neutralizing antibodies and T cells. DeltaFLU provides protection against all influenza A and B strains, including seasonal and pandemic types, and is replication-deficient, meaning it does not form viral progeny and is not shed by recipients.

Other names
deltaFLU LAIVdeltaFLU quadrivalent LAIVFluVaccFluVacc - DNS1Fluvacc delta NS1FLUVACCdelNS1FLUVACCdelNS-1FLUVACCdelNS 1FluVaccΔNS1
02

Targets

IFNL3 (Interferon lambda 3)

Beyond the preview

Go deeper on DeltaFLU.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeltaFLU.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call